Compare HIPO & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HIPO | YDES |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | Taiwan |
| Employees | 540 | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.8M | 543.0M |
| IPO Year | N/A | N/A |
| Metric | HIPO | YDES |
|---|---|---|
| Price | $26.25 | $5.10 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.67 | N/A |
| AVG Volume (30 Days) | ★ 71.6K | 21.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.28 | N/A |
| Revenue Next Year | $22.33 | N/A |
| P/E Ratio | $7.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.92 | $5.00 |
| 52 Week High | $38.98 | $25.00 |
| Indicator | HIPO | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 34.25 |
| Support Level | $24.85 | N/A |
| Resistance Level | $27.12 | $13.19 |
| Average True Range (ATR) | 0.93 | 0.47 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 40.48 | 7.19 |
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.